Facing highly infectious diseases: New trends and current concepts

Clinical Microbiology and Infection

Volumn 15, Issue 8, 2009, Pages 700-705

  Brouqui, Philippe ^a,b  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Bioterrorism; Class 3 and 4 agents; Infection control; Isolation room; SARS

Indexed keywords

AIR POLLUTANT; DISEASE TRANSMISSION; EMERGENCY WARD; ENVIRONMENTAL FACTOR; EPIDEMIC; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYGIENE; INFECTION; INFECTION CONTROL; INTENSIVE CARE UNIT; LABORATORY DIAGNOSIS; LIFESTYLE MODIFICATION; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 69249136295     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02873.x     Document Type: Review

References (50)

1. Centers for Disease Control and Prevention. Laboratory-acquired West Nile virus infections - United States, 2002. MMWR Morb Mortal Wkly Rep 2002; 51: 1133-1135.
2. From the Centers for Disease Control and Prevention. Laboratory-acquired West Nile virus infections -United States, 2002. JAMA 2003; 289: 414-415.
3. Minister of Health Population and Public Health Branch, Center of Emergency Preparedness and Response. Laboratory biosafety guidelines. Health Canada and Ottawa. http://www.phac-aspc.gc.ca/ois-bsl/lbg-Idmbl/ index-eng.php [3rd]. 2004.
4. American Biological Safety Association (ABSA). Risk group classification for infectious agents. http://www.absa.org/riskgroups/index.html. 2009.
5. American Institute of Architectes (AIA). Guidelines for design and construction of hospital and health care facilities. http://www.fgiguidelines.org/. 2009.
6. Armstrong LR, Dembry LM, Rainey PM et al. Management of a Sabia virus-infected patients in a US hospital. Infect Control Hosp Epidemiol 1999; 20: 176-182.
7. Bannister B, Puro V, Fusco FM, Heptonstall J, Ippolito G. Framework for the design and operation of high-level isolation units: Consensus of théEuropean Network of Infectious Diseases. Lancet Infect Dis 2009; 9: 45-56.
8. Brouqui P, Puro V, Fusco FM et al. Lancet Infect Dis in press.
9. Burmeister RW, Tigertt WD, Overholt EL. Laboratory-acquired pneumonie plague. Report of a case and review of previous cases. Ann Intern Med 1962; 56: 789-800.
10. Center for Disease Control and Prevention (CDC). Respiratory hygiene/ caught etiquette. http://www.cdc.gov/flu/professionals/infectioncontrol/ resphygiene.htm. Altanta, GA: Center for Disease Control and Prevention (CDC), 2006.
11. Fung CP, Hsieh TL, Tan KH et al. Rapid creation of a temporary isolation ward for patients with severe acute respiratory syndrome in Taiwan. Infect Control Hosp Epidemiol 2004; 25: 1026-1032.
12. Haas WH, Breuer T, Pfaff G et al. Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis 2003; 36: 1254-1258.
13. Harris JA. Pediatric nosocomial infections: Children are not little adults. Infect Control Hosp Epidemiol 1997; 18: 739-742.
14. Ho SS, Chan PL, Wong PK et al. Eye of the storm: The roles of a radiology department in the outbreak of severe acute respiratory syndrome. AJR Am J Roentgenol 2003; 181: 19-24.
15. Hugonnet S, Pittet D. Transmission of severe acute respiratory syndrome in critical care: Do we need a change? Am J Respir Crit Care Med 2004; 169: 1177-1178.
16. Hummeler K, Davidson WL, Henle W, Laboccetta AC, Ruch HG. Encephalomyelitis due to infection with Herpesvirus simiae (herpes B virus); a report of two fatal, laboratoryacquired cases. N Engl J Med 1959; 261: 64-68.
17. Ippolito G, Nicastri E, Capobianchi M, Di CA, Petrosillo N, Puro V. Hospital preparedness and management of patients affected by viral haemorrhagic fever or smallpox at the Lazzaro Spallanzani Institute, Italy. Euro Surveill 2005; 10: 36-39.
18. Johnson JE, Kadull PJ. Laboratory-acquired Q fever. A report of fifty cases. Am J Med 1966; 41: 391-403.
19. Johnson KM, Monath TP. Imported Lassa fever -reexamining the algorithms. N Engl J Med 1990; 323: 1139-1141.
20. Kawamata J, Yamanouchi T, Dohmae K et al. Control of laboratory acquired hemorrhagic fever with renal syndrome (HFRS) in Japan. Lab Anim Sci 1987; 37: 431-436.
21. Koller DF, Nicholas DB, Goldie RS, Gearing R, Selkirk EK. Bowlby and Robertson revisited: The impact of isolation on hospitalized children during SARS. J Dev Behav Pediatr 2006; 27: 134-140.
22. Kruse RH, Puckett WH, Richardson JH. Biological safety cabinetry. Clin Microbiol Rev 1991; 4: 207-241.
23. Lake GC, Francis E. Six cases of tularemia occurring in laboratory workers. Public Health Rep 1922; 37: 392-413.
24. Lee HW, Johnson KM. Laboratory-acquired infections with Hantaan virus, the etiologic agent of Korean hemorrhagic fever. J Infect Dis 1982; 146: 645-651.
25. Leifer E, Gocke DJ, Bourne H. Lassa fever, a new virus disease of man from West Africa. II. Report of a laboratory-acquired infection treated with plasma from a person recently recovered from the disease. Am J Trop Med Hyg 1970; 19: 677-679.
26. Li X, Huang J, Zhang H. An analysis of hospital preparedness capacity for public health emergency in four regions of China: Beijing, Shandong, Guangxi, and Hainan. BMC Public Health 2008; 8: 319.
27. Lim PL, Kurup A, Gopalakrishna G et al. Laboratory-acquired severe acute respiratory syndrome. N Engl J Med 2004; 350: 1740-1745.
28. Loeb M, Zando I, Orvidas MC, Bialachowski A, Groves D, Mahoney J. Laboratory-acquired vaccinia infection. Can Commun Dis Rep 2003; 29: 134-136.
29. Loeb MB. Severe acute respiratory syndrome: Preparedness, management, and impact. Infect Control Hosp Epidemiol 2004; 25: 1017-1019.
30. Mondy C, Cardenas D, Avila M. The role of an advanced practice public health nurse in bioterrorism preparedness. Public Health Nurs 2003; 20: 422-431.
31. O'Connell NH, Humphreys H. Intensive care unit design and environmental factors in the acquisition of infection. J Hosp Infect 2000; 45: 255-262.
32. Orellana C. Laboratory-acquired SARS raises worries on biosafety. Lancet Infect Dis 2004; 4: 64.
33. Oster CN, Burke DS, Kenyon RH, Ascher MS, Harber P, Pedersen CE Jr. Laboratory-acquired Rocky Mountain spotted fever. The hazard of aerosol transmission. N Engl J Med 1977; 297: 859-863.
34. Peiris JS. Severe acute respiratory syndrome (SARS). J Clin Virol 2003; 28: 245-247.
35. Phoenix Control an Honeywell International, Inc. Health care facility design resourse. http://www.phoenixcontrols.com/. Phoenix Control Corporation, 2003.
36. Purssell E. Preventing nosocomial infection in paediatric wards. J Clin Nurs 1996; 5: 313-318.
37. Raoult D, Renesto P, Brouqui P. Laboratory infection of a technician by mimivirus. Ann Intern Med 2006; 144: 702-703.
38. Schlech WF III, Turchik JB, Westlake RE Jr, Klein GC, Band JD, Weaver RE. Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis). N Engl J Med 1981; 305: 1133-1135.
39. Senior K. Recent Singapore SARS case a laboratory accident. Lancet Infect Dis 2003; 3: 679.
40. Seto WH, Tsang D, Yung RW et al. Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet 2003; 361: 1519-1520.
41. Shi Y, Yi Y, Li P et al. Diagnosis of severe acute respiratory syndrome (SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay. J Clin Microbiol 2003; 41: 5781-5782.
42. Srinivasan A, McDonald LC, Jernigan D et al. Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities. Infect Control Hosp Epidemiol 2004; 25: 1020-1025.
43. Trexler PC, Emond RT, Evans B. Negative-pressure plastic isolator for patients with dangerous infections. Br Med J 1977; 2: 559-561.
44. Tsou IY, Goh JS, Kaw GJ, Chee TS. Severe acute respiratory syndrome: management and reconfiguration of a radiology department in an infectious disease situation. Radiology 2003; 229: 21-26.
45. U.S. Department of Health and Human Services Center for Diseases Control and Prevention and National Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories (BMBL). http://www.cdc.gov/ od/ohs/biosfty/bmbl5/bmbl5toc.htm [5th]. 2007.
46. Avsic-Zupanc T, Poljak M, Maticic M et al. Laboratory acquired tick-borne meningoencephalitis: Characterisation of virus strains. Clin Diagn Virol 1995; 4: 51-59.
47. WHO, SEARO. Pratical guidelines for infection control in health care facilities. http://www.searo.who.int/LinkFiles/ PublicationsPracticalguidelinSEAROpub-41.pdf. 2004.
48. Woo JH, Cho JY, Kim YS et al. A case of laboratory-acquired murine typhus. Korean J Intern Med 1990; 5: 118-122.
49. World Health Organisation (WHO). Laboratory biosafety manual, 3rd edn. http://www.who.int/csr/resources/publications/biosafety/ WHOCDSCSRLYO20041l/en/. 2004.
50. Wright LJ, Barker LF, Mickenberg ID, Wolff SM. Laboratory-acquired typhus fevers. Ann Intern Med 1968; 69: 731-738.